HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Man rubbing wrist | Image credit: pikselstock - stock.adobe.com
Individuals With HIV Have an Increased Risk of Osteoporosis

September 11th 2025

Bone density was found to be lower in those diagnosed with HIV vs those who were HIV-negative.

Blood donation | Image credit: New Africa - stock.adobe.com
Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods

September 8th 2025

Molecular structure of INSTI | Image credit: Сергей Шиманович - stock.adobe.com
ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy

September 4th 2025

HIV test | Image credit: gamjai - stock.adobe.com
Cotesting for HIV, STIs Improved Screening Practices for HIV

September 2nd 2025

Black woman HIV awareness | Image credit: AS Photo Family - stock.adobe.com
ART Adherence Linked to Patient-Centered Care From Patient-Provider Relationships

August 29th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
September 16th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 16th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Identifying Missed Opportunities for HIV Testing in Clinical Settings
July 3rd 2018

Identifying Missed Opportunities for HIV Testing in Clinical Settings

Jaime Rosenberg
Pinpointing and eliminating missed opportunities for HIV testing and diagnosis in healthcare settings has the potential to reduce HIV transmission, especially among high-risk groups.
What We're Reading: Trauma Fees Inflate ED Bills; CDC Chief Switches View; Painkiller Shortages in Hospitals
July 2nd 2018

What We're Reading: Trauma Fees Inflate ED Bills; CDC Chief Switches View; Painkiller Shortages in Hospitals

AJMC Staff
Collected emergency department (ED) bills show that trauma fees are costly and swing widely; the head of the CDC has changed his mind about opposing the use of condoms and needle programs as ways to stop the spread of sexually transmitted diseases; EDs around the country are struggling with shortages of painkillers and cardiac drugs.
Researchers Highlight Disproportionate HIV Incidence Among African Americans, Recommend Plan of Action
June 29th 2018

Researchers Highlight Disproportionate HIV Incidence Among African Americans, Recommend Plan of Action

Jaime Rosenberg
African Americans are still disproportionately affected by HIV compared with other ethnic groups.
Increasing Awareness and Early Diagnosis on National HIV Testing Day
June 27th 2018

Increasing Awareness and Early Diagnosis on National HIV Testing Day

Jaime Rosenberg
As tomorrow marks National HIV Testing Day, over 400 organizations and clinics nationwide are spearheading efforts to promote testing.
Many People at Risk of Contracting HIV Are Not Screened Annually
June 24th 2018

Many People at Risk of Contracting HIV Are Not Screened Annually

Jaime Rosenberg
Many people at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.
Viral Suppression in People With HIV Associated With Reduced Cancer Risk
June 21st 2018

Viral Suppression in People With HIV Associated With Reduced Cancer Risk

Jaime Rosenberg
For people living with HIV who achieve viral suppression from antiretroviral therapy, there is a reduced risk of developing both AIDS-defining cancer and non-AIDS-defining cancer.
Walgreens, Greater Than AIDS Team Up With Health Organizations to Provide Free HIV Testing
June 13th 2018

Walgreens, Greater Than AIDS Team Up With Health Organizations to Provide Free HIV Testing

Jaime Rosenberg
On National HIV Testing Day on June 27, Walgreens and Greater Than AIDS will partner with over 200 health and community organizations to provide free HIV testing and information at Walgreens stores in over 180 cities.
NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers
June 13th 2018

NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers

Jaime Rosenberg
The 70 National Cancer Institute (NCI)-designated cancer centers underscored the importance of increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the human papillomavirus (HPV).
Early ART Initiation Significantly Reduces Treatment Failure in Patients With HIV
June 8th 2018

Early ART Initiation Significantly Reduces Treatment Failure in Patients With HIV

Jaime Rosenberg
New study results have concluded that antiretroviral therapy (ART) initiation within 30 days of HIV diagnosis is associated with a significantly reduced risk of treatment dropout and failure.
Successful Management of HIV Is Outpacing That of Diabetes in Women
June 7th 2018

Successful Management of HIV Is Outpacing That of Diabetes in Women

Jaime Rosenberg
Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.
PEPFAR Reaches 14 Million People With HIV Globally
May 31st 2018

PEPFAR Reaches 14 Million People With HIV Globally

Jaime Rosenberg
As this month marks the 15th anniversary, the US President’s Emergency Plan for AIDS Relief (PEPFAR) now supports over 14 million people globally with HIV treatment.
Study Will Assess Safety of HIV-to-HIV Kidney Transplantation
May 29th 2018

Study Will Assess Safety of HIV-to-HIV Kidney Transplantation

Jaime Rosenberg
The HOPE in Action Multicenter Kidney Study will examine the safety of HIV-to-HIV kidney transplantation.
Podcast: This Week in Managed Care—Impact of Hypertension Guideline Update and Other Health News
May 26th 2018

Podcast: This Week in Managed Care—Impact of Hypertension Guideline Update and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: May 25, 2018
May 25th 2018

This Week in Managed Care: May 25, 2018

This week, the top managed care stories include the finding that new guidelines will mean the number of people with hypertension will soar; research finds that most diabetes apps don’t lower glycated hemoglobin; and a health plan announced its plan to fight housing instability.
Site Logo
May 25th 2018

Study Summary: HIV-1 Resistance to Integrase Strand Transfer Inhibitors

You J, Wang H, Huang X, et al. Therapy-emergent drug resistance to integrase strand transfer inhibitors in HIV-1 patients: a subgroup meta-analysis of clinical trials. PLoS One. 2016, 11(8):e0160087. doi: 10.1371/journal.pone.0160087.
Early Initiation of Antiretroviral Therapy Can Prevent HIV-Related Brain Damage
May 23rd 2018

Early Initiation of Antiretroviral Therapy Can Prevent HIV-Related Brain Damage

Jaime Rosenberg
Neurological damage begins early in infection, particularly during untreated infection, and worsens with the continued absence of combination antiretroviral therapy (cART). However, initiating cART may halt further deterioration, emphasizing the importance of early cART.
FDA Warns of Neural Tube Birth Defects From HIV Drug Dolutegravir
May 21st 2018

FDA Warns of Neural Tube Birth Defects From HIV Drug Dolutegravir

Jaime Rosenberg
The FDA has warned of serious cases of neural tube birth defects involving the brain, spine, and spinal cord affecting babies born to women with HIV being treated with dolutegravir.
FDA Expands Indication for PrEP to Reduce Risk of HIV in Adolescents
May 18th 2018

FDA Expands Indication for PrEP to Reduce Risk of HIV in Adolescents

Jaime Rosenberg
The FDA has approved an expanded indication for Gilead Science’s emtricitabine/tenofovir disoproxil fumarate (Truvada) to reduce the risk of HIV in at-risk adolescents. Truvada for pre-exposure prophylaxis (PrEP) was first approved for the use in adults in 2012.
FDA Releases Draft Guidance on HIV Treatment Development For Pediatric Patients
May 16th 2018

FDA Releases Draft Guidance on HIV Treatment Development For Pediatric Patients

Jaime Rosenberg
The FDA has drafted new recommendations on the development of drugs to treat pediatric patients with HIV meant to be applied on a global scale.
Team Identifies HIV Hotspots to Target Prevention, Treatment Efforts
May 12th 2018

Team Identifies HIV Hotspots to Target Prevention, Treatment Efforts

Jaime Rosenberg
Through an HIV heatmap, as well as an extensive survey and customized web-based software to connect social determinants with viral suppression rates, an HIV primary care program is working to reduce the number of new HIV diagnoses and increase viral suppression rates in Long Island and Queens.
Prostate, Lung Cancers Projected to Be Most Common Cancers Among HIV Population by 2030
May 9th 2018

Prostate, Lung Cancers Projected to Be Most Common Cancers Among HIV Population by 2030

Jaime Rosenberg
The total cancer burden among people living with HIV will decrease from 8150 cases in 2010 to 6690 cases in 2030, and prostate and lung cancers will emerge as the most common types of cancer facing the patient population.
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 5th 2018

Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch

Jaime Rosenberg
Aimee Tharaldson, PharmD, a senior clinical consultant in Emerging Therapeutics for Express Scripts, discusses specialty drugs that have recently been approved, and which we will likely see approved in the remainder of the year.
Tahir Amin: Increasing Access to Affordable HIV Drugs Through Patent Opposition
May 4th 2018

Tahir Amin: Increasing Access to Affordable HIV Drugs Through Patent Opposition

Tahir Amin, DipLP, co-founder and co-executive director of the Initiative for Medicines, Access, and Knowledge, discusses the organization’s focus on patent opposition for HIV drugs, the results of their work, and what efforts are still needed.
Gaps in Care up to Nine Months Do Not Worsen Viral Load in Patients With HIV
May 2nd 2018

Gaps in Care up to Nine Months Do Not Worsen Viral Load in Patients With HIV

Jaime Rosenberg
Patients with gaps between HIV primary care visits of 6 months up until 9 months did not have a significant difference in viral suppression loads. However, with gaps of 12 months or more, 23% of patients became unsuppressed.
Phase 1 Trial Will Test Safety of Vaccine for HIV Prevention
April 28th 2018

Phase 1 Trial Will Test Safety of Vaccine for HIV Prevention

Jaime Rosenberg
Researchers from the University of Massachusetts Medical School will test the safety and tolerability of a vaccine that may have the potential to prevent HIV infection.
Long-Term Analysis Highlights Half Trillion Dollars Spent on HIV/AIDS
April 25th 2018

Long-Term Analysis Highlights Half Trillion Dollars Spent on HIV/AIDS

Jaime Rosenberg
Between 2000 and 2015, $562.6 billion was spent on HIV/AIDS, with most spending occurring in high-income and upper-income countries and out-of-pocket spending accounting for less than 10%, according to the first long-term, comprehensive analysis of funding for the disease.
Site Logo
April 24th 2018

Specialty Drug Pipeline Review Focuses on Competition, Cancer Drugs

Allison Inserro
At the Academy of Managed Care Pharmacy's Managed Care & Specialty Pharmacy Annual Meeting, held April 23-26, in Boston, Massachusetts, an overflow capacity crowd gathered for one of the meeting’s yearly highlights­: Specialty Pharmaceuticals in Development. Aimee Tharaldson, PharmD, a senior clinical consultant in Emerging Therapeutics for Express Scripts, talked about the key trends in the specialty drug market, including cancer drugs, new competition, and orphan drugs.
Podcast: Special Considerations in HIV Management
April 24th 2018

Podcast: Special Considerations in HIV Management

A panel of experts in infectious disease and managed care to discuss management of HIV, including the need for individualized care and the role for newer treatments options.
What's New in Adult and Adolescent, Perinatal HIV Guidelines
April 20th 2018

What's New in Adult and Adolescent, Perinatal HIV Guidelines

Jaime Rosenberg
AIDSinfo, a portal from the National Institutes of Health, has outlined recent changes that have been made to the adult, adolescent, and perinatal HIV guidelines, including the incorporation of people-first language.
Patients With HIV Face Increased Risk of Mortality From Lung Cancer
April 18th 2018

Patients With HIV Face Increased Risk of Mortality From Lung Cancer

Kelly Davio
The increased risk of cancer in patients with HIV has been well defined, and some studies have suggested that patients with HIV have not only a higher risk of lung cancer, but also an increased risk of mortality from their cancer than patients without HIV.
<1
...
232425262728293031
...
33>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo